Pharmaceutical Research and Manufacturers of America
Around the web
-
Celgene's Robert J. Hugin Becomes PhRMA Board Chairman; Ian C. Read, Kenneth C. Frazier Assume New Posts
-- Robert J. Hugin , chairman and CEO of Celgene Corporation, was elected chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) today at the trade association's annual meeting. Also elected were Ian C. Read , president and CEO of Pfizer from PR Newswire Read more »
-
Brand drug 'product hopping' comes under scrutiny
and efficacy profile, or is projected to substantially improve patient compliance," said a spokeswoman for the Pharmaceutical Research and Manufacturers of America. Although product-hopping has gone on for years, of late it has been attracting more attention from Thomson Reuters News & Insight Read more »
-
US pharma: 907 biologic drugs and vaccines now in R&D
report, from the Pharmaceutical Research and Manufacturers of America (PhRMA), says that these products, which are all now either in human clinical trials or under review by the Food and Drug Administration (FDA), include the following, by therapeutic category: from PharmaTimes Read more »
-
By the Numbers: Number of Drugs in Clinical Development for Different Tumor Types
to a 2012 study by Pharmaceutical Research and Manufacturers of America (PhRMA), 981 medicines and vaccines to fight cancer were in testing by U.S. companies. Drugs designed to target colorectal cancer ranked among the top ten. The U.S. has perhaps the most from Gastroenterology and Endoscopy News Read more »
-
Trade Group Study: Hundreds of Rare Disease Drugs in Development
to a new report released last month by the trade group Pharmaceutical Research and Manufacturers of America (PhRMA), the biopharmaceutical pipeline is innovative and robust, with a high percentage of potential first-in-class medicines (meaning a new treatment from Highlight Health Read more »
